Results 121 to 128 of about 5,607 (128)

Graded Administration of Second Dose of Moderna and Pfizer-BioNTech COVID-19 mRNA Vaccine in Patients with Hypersensitivity to First Dose

Open Forum Infectious Diseases, 2021
Peter Capucilli, Allison Ramsey, Edward E Walsh   +2 more
exaly  

COVID-19: Perceived Infection Risk and Barriers to Uptake of Pfizer-BioNTech and Moderna Vaccines Among Community Healthcare Workers

Journal of Racial and Ethnic Health Disparities, 2021
Tolulope B Famuyiro, Mukaila A Raji
exaly  

Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults — United States, August–December 2021

Morbidity and Mortality Weekly Report, 2022
Nicholas M Mohr, Ithan D Peltan, Akram Khan   +2 more
exaly  

ModeRNA: a tool for comparative modeling of RNA 3D structure

Nucleic Acids Research, 2011
Tomasz Puton, Janusz M Bujnicki
exaly  

Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant — National Healthcare Safety Network, March 1–August 1, 2021

Morbidity and Mortality Weekly Report, 2021
exaly  

Incidence and Characteristics of Delayed Injection Site Reaction to the mRNA-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine (Moderna) in a Cohort of Hospital Employees

Clinical Infectious Diseases, 2022
exaly  

ModeRNA server: an online tool for modeling RNA 3D structures

Bioinformatics, 2011
Kaja Milanowska, Tomasz Puton, Janusz M Bujnicki   +2 more
exaly  

Lymphohistiocytic Myocarditis Possibly Due to Moderna mRNA-1273 Vaccine

American Journal of Clinical Pathology, 2022
exaly